Contact PI/Project LeaderALEKSUNES, LAUREN M Other PIs
Awardee OrganizationRUTGERS BIOMEDICAL AND HEALTH SCIENCES
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Given their physiochemical properties, medications and dietary supplements often require active transport using
solute carriers (SLC) and ATP-binding cassette (ABC) transporters to cross trophoblast barriers. These same
transporters are also involved in the delivery of nutrients to the fetus and one unintentional consequence of drug
therapy during pregnancy can be disruption of these shared systems. Therefore, understanding the interplay
between SLC and ABC transporters in the placental disposition of drugs and nutrients is one key step to optimizing
therapeutic interventions that improve perinatal healthcare. Our research team has championed the advancement
of novel approaches to study SLC and ABC transporters in the placenta. To expand these efforts, we have created
the Integrated Transporter Elucidation Center (InTEC) which leverages translational research expertise across 4
academic institutions. Our central hypothesis is that novel regulation and functions of placental transporters
can be elucidated using integrated experimental, epidemiological, and modeling approaches. Together,
data and models generated can predict the placental disposition of therapeutics and nutrients and their
subsequent effects on fetal development. To accomplish this goal, we will 1) identify critical factors that regulate
placental transporters using state-of-the-art quantitative targeted absolute proteomics and genetics in a US-based
birth cohort; 2) develop a novel computational modeling framework that predicts maternal-fetal chemical disposition
according to placental transporter functions and regulation; and 3) evaluate SLC and ABC transport in novel
placenta-on-a-chip microphysiological systems. We will test nutrients, supplements, drugs, and toxicants as
substrates and inhibitors of placental transporters. InTEC will enable rapid acceleration of placenta transporter
research and establish best practices for transporter biology. Resources and datasets will be disseminated via our
CIIPro webportal created in 2017. Unique training opportunities will be provided to early career scientists
(undergraduate students, MS/MPH/PhD students, and postdoc fellows) and clinicians (obstetrics residents and
fellows) at the intersections of pharmacology, computational biology, public health, maternal-fetal medicine, and
biomedical engineering. Through innovative research and training, InTEC will lead to novel breakthroughs in the
field of placental transport and ensure a well-trained workforce to improve maternal and perinatal health.
Public Health Relevance Statement
PROJECT NARRATIVE
The placenta delivers nutrients to the baby and protects against damage from medications and toxicants. We will
develop new scientific approaches to study how chemicals pass across the placenta aided by transporter proteins
and train scientists and clinicians at the intersections of pharmacology, chemistry, computer science, public health,
medicine, and bioengineering.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
090299830
UEI
YVVTQD8CJC79
Project Start Date
14-September-2023
Project End Date
30-June-2028
Budget Start Date
01-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$1,055,800
Direct Costs
$935,268
Indirect Costs
$120,532
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$808,300
2024
NIH Office of the Director
$247,500
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5UC2HD113039-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5UC2HD113039-02
Patents
No Patents information available for 5UC2HD113039-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5UC2HD113039-02
Clinical Studies
No Clinical Studies information available for 5UC2HD113039-02
News and More
Related News Releases
No news release information available for 5UC2HD113039-02
History
No Historical information available for 5UC2HD113039-02
Similar Projects
No Similar Projects information available for 5UC2HD113039-02